Nonsurgical Therapy for Early-Stage Lung Cancer.
Hematol Oncol Clin North Am
; 37(3): 499-512, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-37024386
ABSTRACT
Treatment options for medically inoperable, early-stage non-small cell lung cancer (NSCLC) include stereotactic ablative radiotherapy (SABR) and percutaneous image guided thermal ablation. SABR is delivered over 1-5 sessions of highly conformal ablative radiation with excellent tumor control. Toxicity is depending on tumor location and anatomy but is typically mild. Studies evaluating SABR in operable NSCLC are ongoing. Thermal ablation can be delivered via radiofrequency, microwave, or cryoablation, with promising results and modest toxicity. We review the data and outcomes for these approaches and discuss ongoing studies.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Radiosurgery
/
Carcinoma, Non-Small-Cell Lung
/
Hyperthermia, Induced
/
Lung Neoplasms
Limits:
Humans
Language:
En
Journal:
Hematol Oncol Clin North Am
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2023
Type:
Article